Key result
Framingham risk score overestimates CVD risk in Hispanics by ~68%.
Why the study?
The use and validity of cardiovascular risk prediction models in Latin America and among Hispanic populations in the United States had not been adequately assessed.
Are cardiovascular risk prediction models valid for estimating CVD risk in Latin American and US Hispanic populations?
Systematic Review (n=13,142)
Yes
Are cardiovascular risk prediction models valid for estimating CVD risk in Latin American and US Hispanic populations?
The Framingham risk score likely overestimates cardiovascular disease risk in Hispanic populations when not properly recalibrated, highlighting the need for population-specific risk models.
May overestimate CVD risk if unadjusted in Hispanics; challenges Framingham generalizability and supports ethnicity-specific recalibration.
OBJECTIVE: To assess the use and validity of prediction models to estimate the risk of cardiovascular disease (CVD) in Latin America and among Hispanic populations in the United States of America. METHODS: This was a systematic review of three databases: Ovid MEDLINE (1 January 1950-15 April 2010), LILACS (1 January 1988-15 April 2010), and EMBASE (1 January 1988-15 April 2010). MeSH search terms and domains were related to CVD, prediction rules, Latin America (including the Caribbean), and Hispanics in the United States. Database searches were supplemented by correspondence with experts in the field. RESULTS: A total of 1 655 abstracts were identified, of which five cohorts with a total of 13 142 subjects met inclusion criteria. A Mexican cohort showed that the predicted/observed event-rate ratio for coronary heart disease (CHD) according to the Framingham risk score (FRS) was 1.68 (95% CI, 1.26-2.11); incident myocardial infarction, 1.36 (95% CI, 0.90-1.83); and CHD death, 1.21 (95% CI, 0.43-2.00). In Ecuador, a prediction model for CVD and total deaths in hypertensive patients had an area under the curve (AUC) of 0.79 (95% CI, 0.72-0.86), while the World Health Organization method had an AUC of 0.74 (95% CI, 0.67-0.82). A study predicting mortality risk in people with Chagas' disease had an AUC of 0.81 (95% CI, 0.72-0.90). Among a United State s cohort that included Hispanics, FRS overestimated CVD risk for Hispanics with an AUC of 0.69. Another study in the United States that assessed FRS factors predicting CVD death among Mexican-Americans had an AUC of 0.78. CONCLUSIONS: The evidence regarding CVD risk prediction rules in Latin America or among Hispanics in the United States is modest at best. It is likely that the FRS overestimates CVD risk in Hispanics when not properly recalibrated.
No takes yet. Share an insight, caveat, or question.
Cortés-Bergoderi et al. (2012) conducted a systematic review in Cardiovascular disease (n=13,142). Cardiovascular risk prediction models (e.g., Framingham risk score) was evaluated on Validity of prediction models to estimate the risk of cardiovascular disease. The Framingham risk score overestimates CVD risk in Hispanics, with a predicted/observed CHD event-rate ratio of 1.68 (95% CI, 1.26-2.11) in a Mexican cohort and an AUC of 0.69 in a US cohort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: